ALLR
Price
$1.07
Change
+$0.04 (+3.88%)
Updated
May 8 closing price
Capitalization
17.53M
BLTE
Price
$60.93
Change
-$0.40 (-0.65%)
Updated
May 8 closing price
Capitalization
1.98B
5 days until earnings call
Ad is loading...

ALLR vs BLTE

Header iconALLR vs BLTE Comparison
Open Charts ALLR vs BLTEBanner chart's image
Allarity Therapeutics
Price$1.07
Change+$0.04 (+3.88%)
Volume$651.44K
Capitalization17.53M
Belite Bio
Price$60.93
Change-$0.40 (-0.65%)
Volume$25.32K
Capitalization1.98B
ALLR vs BLTE Comparison Chart
Loading...
ALLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALLR vs. BLTE commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLR is a Hold and BLTE is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (ALLR: $1.07 vs. BLTE: $60.93)
Brand notoriety: ALLR and BLTE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLR: 35% vs. BLTE: 63%
Market capitalization -- ALLR: $17.53M vs. BLTE: $1.98B
ALLR [@Biotechnology] is valued at $17.53M. BLTE’s [@Biotechnology] market capitalization is $1.98B. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLR’s FA Score shows that 1 FA rating(s) are green whileBLTE’s FA Score has 0 green FA rating(s).

  • ALLR’s FA Score: 1 green, 4 red.
  • BLTE’s FA Score: 0 green, 5 red.
According to our system of comparison, ALLR is a better buy in the long-term than BLTE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLR’s TA Score shows that 6 TA indicator(s) are bullish while BLTE’s TA Score has 4 bullish TA indicator(s).

  • ALLR’s TA Score: 6 bullish, 4 bearish.
  • BLTE’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ALLR is a better buy in the short-term than BLTE.

Price Growth

ALLR (@Biotechnology) experienced а -8.55% price change this week, while BLTE (@Biotechnology) price change was -1.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.66%. For the same industry, the average monthly price growth was +15.23%, and the average quarterly price growth was -12.40%.

Reported Earning Dates

ALLR is expected to report earnings on Mar 31, 2025.

BLTE is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (-3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLTE($1.98B) has a higher market cap than ALLR($17.5M). BLTE YTD gains are higher at: -3.439 vs. ALLR (-8.547). ALLR has higher annual earnings (EBITDA): -18.26M vs. BLTE (-35.42M). ALLR (0) and BLTE (0) have equivalent revenues.
ALLRBLTEALLR / BLTE
Capitalization17.5M1.98B1%
EBITDA-18.26M-35.42M52%
Gain YTD-8.547-3.439249%
P/E RatioN/AN/A-
Revenue00-
Total Cash18.5MN/A-
Total Debt1.34MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ALLRBLTE
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
65%
Advances
ODDS (%)
Bullish Trend 9 days ago
80%
Bullish Trend 7 days ago
75%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
View a ticker or compare two or three
Ad is loading...
ALLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OPRX9.910.43
+4.54%
OptimizeRx Corp
PHVS17.04-0.06
-0.35%
Pharvaris NV
WRB72.72-0.36
-0.49%
WR Berkley Corp
SGRY22.68-0.48
-2.07%
Surgery Partners
PAVM0.67-0.06
-8.49%
PAVmed

ALLR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLR has been closely correlated with SNPX. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if ALLR jumps, then SNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLR
1D Price
Change %
ALLR100%
+3.88%
SNPX - ALLR
87%
Closely correlated
+1.67%
AGEN - ALLR
87%
Closely correlated
+3.05%
RNAC - ALLR
86%
Closely correlated
+2.66%
NCNA - ALLR
86%
Closely correlated
-65.83%
NRXP - ALLR
81%
Closely correlated
+4.06%
More